Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin

Abstract Relaxin family peptide receptor 2 (RXFP2) is a GPCR known for its role in reproductive function. It is structurally related to the human relaxin receptor RXFP1 and can be activated by human gene-2 (H2) relaxin as well as its cognate ligand insulin-like peptide 3 (INSL3). Both receptors poss...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shoni Bruell, Ashish Sethi, Nicholas Smith, Daniel J. Scott, Mohammed Akhter Hossain, Qing-Ping Wu, Zhan-Yun Guo, Emma J. Petrie, Paul R. Gooley, Ross A. D. Bathgate
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8eaad5d63dd34da1a869adfafa703bc1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8eaad5d63dd34da1a869adfafa703bc1
record_format dspace
spelling oai:doaj.org-article:8eaad5d63dd34da1a869adfafa703bc12021-12-02T11:52:58ZDistinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin10.1038/s41598-017-03638-42045-2322https://doaj.org/article/8eaad5d63dd34da1a869adfafa703bc12017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-03638-4https://doaj.org/toc/2045-2322Abstract Relaxin family peptide receptor 2 (RXFP2) is a GPCR known for its role in reproductive function. It is structurally related to the human relaxin receptor RXFP1 and can be activated by human gene-2 (H2) relaxin as well as its cognate ligand insulin-like peptide 3 (INSL3). Both receptors possess an N-terminal low-density lipoprotein type a (LDLa) module that is necessary for activation and is joined to a leucine-rich repeat domain by a linker. This linker has been shown to be important for H2 relaxin binding and activation of RXFP1 and herein we investigate the role of the equivalent region of RXFP2. We demonstrate that the linker’s highly-conserved N-terminal region is essential for activation of RXFP2 in response to both ligands. In contrast, the linker is necessary for H2 relaxin, but not INSL3, binding. Our results highlight the distinct mechanism by which INSL3 activates RXFP2 whereby ligand binding mediates reorientation of the LDLa module by the linker region to activate the RXFP2 transmembrane domains in conjunction with the INSL3 A-chain. In contrast, relaxin activation of RXFP2 involves a more RXFP1-like mechanism involving binding to the LDLa-linker, reorientation of the LDLa module and activation of the transmembrane domains by the LDLa alone.Shoni BruellAshish SethiNicholas SmithDaniel J. ScottMohammed Akhter HossainQing-Ping WuZhan-Yun GuoEmma J. PetriePaul R. GooleyRoss A. D. BathgateNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Shoni Bruell
Ashish Sethi
Nicholas Smith
Daniel J. Scott
Mohammed Akhter Hossain
Qing-Ping Wu
Zhan-Yun Guo
Emma J. Petrie
Paul R. Gooley
Ross A. D. Bathgate
Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin
description Abstract Relaxin family peptide receptor 2 (RXFP2) is a GPCR known for its role in reproductive function. It is structurally related to the human relaxin receptor RXFP1 and can be activated by human gene-2 (H2) relaxin as well as its cognate ligand insulin-like peptide 3 (INSL3). Both receptors possess an N-terminal low-density lipoprotein type a (LDLa) module that is necessary for activation and is joined to a leucine-rich repeat domain by a linker. This linker has been shown to be important for H2 relaxin binding and activation of RXFP1 and herein we investigate the role of the equivalent region of RXFP2. We demonstrate that the linker’s highly-conserved N-terminal region is essential for activation of RXFP2 in response to both ligands. In contrast, the linker is necessary for H2 relaxin, but not INSL3, binding. Our results highlight the distinct mechanism by which INSL3 activates RXFP2 whereby ligand binding mediates reorientation of the LDLa module by the linker region to activate the RXFP2 transmembrane domains in conjunction with the INSL3 A-chain. In contrast, relaxin activation of RXFP2 involves a more RXFP1-like mechanism involving binding to the LDLa-linker, reorientation of the LDLa module and activation of the transmembrane domains by the LDLa alone.
format article
author Shoni Bruell
Ashish Sethi
Nicholas Smith
Daniel J. Scott
Mohammed Akhter Hossain
Qing-Ping Wu
Zhan-Yun Guo
Emma J. Petrie
Paul R. Gooley
Ross A. D. Bathgate
author_facet Shoni Bruell
Ashish Sethi
Nicholas Smith
Daniel J. Scott
Mohammed Akhter Hossain
Qing-Ping Wu
Zhan-Yun Guo
Emma J. Petrie
Paul R. Gooley
Ross A. D. Bathgate
author_sort Shoni Bruell
title Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin
title_short Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin
title_full Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin
title_fullStr Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin
title_full_unstemmed Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin
title_sort distinct activation modes of the relaxin family peptide receptor 2 in response to insulin-like peptide 3 and relaxin
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/8eaad5d63dd34da1a869adfafa703bc1
work_keys_str_mv AT shonibruell distinctactivationmodesoftherelaxinfamilypeptidereceptor2inresponsetoinsulinlikepeptide3andrelaxin
AT ashishsethi distinctactivationmodesoftherelaxinfamilypeptidereceptor2inresponsetoinsulinlikepeptide3andrelaxin
AT nicholassmith distinctactivationmodesoftherelaxinfamilypeptidereceptor2inresponsetoinsulinlikepeptide3andrelaxin
AT danieljscott distinctactivationmodesoftherelaxinfamilypeptidereceptor2inresponsetoinsulinlikepeptide3andrelaxin
AT mohammedakhterhossain distinctactivationmodesoftherelaxinfamilypeptidereceptor2inresponsetoinsulinlikepeptide3andrelaxin
AT qingpingwu distinctactivationmodesoftherelaxinfamilypeptidereceptor2inresponsetoinsulinlikepeptide3andrelaxin
AT zhanyunguo distinctactivationmodesoftherelaxinfamilypeptidereceptor2inresponsetoinsulinlikepeptide3andrelaxin
AT emmajpetrie distinctactivationmodesoftherelaxinfamilypeptidereceptor2inresponsetoinsulinlikepeptide3andrelaxin
AT paulrgooley distinctactivationmodesoftherelaxinfamilypeptidereceptor2inresponsetoinsulinlikepeptide3andrelaxin
AT rossadbathgate distinctactivationmodesoftherelaxinfamilypeptidereceptor2inresponsetoinsulinlikepeptide3andrelaxin
_version_ 1718394939273904128